Israel begins fourth dose of COVID-19 vaccine trial

(JERUSALEM) – Israel has begun testing the fourth dose of vaccine against corona virus in what is believed to be the first study of its kind.

The trial began at Sheba Medical Center, on the outskirts of Tel Aviv, with 150 health workers who received the booster dose in August receiving the fourth dose of the drug. Pfizer / BioNTech Vaccine. Staff members receiving the supplement were tested and found to have low levels of antibodies.

The trial comes as Israeli officials have considered deploying a second wave of booster injections to its population as the country grapples with a growing number of infections with the virus. new omicron variant.

Read more: Vaccine Scientists Are TIME’s 2021 Hero of the Year

Professor Jacob Lavee, former director of the heart transplant unit at Sheba, said “hopefully, we will be able to show here … that this fourth enhancer does indeed provide protection against omicron, which is much needed.”

Israel launched a world-leading vaccination campaign earlier this year. Just over 4.2 million of Israel’s 9.3 million have received the third dose of the Pfizer/BioNTech vaccine.

Israel has recorded at least 8,242 coronavirus deaths since the pandemic began. Israel begins fourth dose of COVID-19 vaccine trial

Aila Slisco

Daily Nation Today is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – The content will be deleted within 24 hours.

Related Articles

Back to top button